Skip to content

Clinical trials

Phase 1 Respiratory Tract Diseases trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Respiratory Tract Diseases Phase: Phase 1 Clear all

41 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20094
20123
20132
20172
20182
20191
20202
20213
20225
20233
20241
20251
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed29
Terminated5
Recruiting3
Active, not recruiting1
Enrolling by invitation1
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Blueprint Medicines Corporation3
Revolution Medicines, Inc.3
CanSino Biologics Inc.2
FDA Office of Orphan Products Development2
Guangzhou JOYO Pharma Co., Ltd2
Medicago2
National Center for Research Resources (NCRR)2
Pulmatrix Inc.2
University of Alabama at Birmingham2
AIRNA Corporation1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Respiratory Tract Diseases41
Lung Diseases23
Cystic Fibrosis10
Carcinoma, Non-Small-Cell Lung8
Genetic Diseases, Inborn8
Lung Neoplasms8
Neoplasms8
Neoplasms by Site8
Rare Diseases8
Respiratory Tract Neoplasms8

Trials

Showing 51 to 41 of 41. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.